The possibility of a new drug to ward off the most serious symptoms of Covid-19 is welcome news, but it may come with two important costs.
Category: pharma & healthcare
Successful Multimodal Covid Control In Summer Camps
A new CDC report demonstrates how using multiple Covid-19 prevention strategies at nine US overnight summer camps was highly effective in preventing transmission of Covid-19, even in the wake of the Delta variant.
America’s New Triage: Covid Crisis Standards Of Care
When crisis standards of care are invoked statewide, as they are today, it is a grim admission that the entire health system is overwhelmed.
Origin: Very Close Relatives Of SARS-CoV-2 Identified In Laotian Bats
A recent study from the Pasteur Institute, Temmam et al., investigates viruses endemic to the bats of Southeast Asia.
Experts Say Worst Of Covid-19 Is Behind Us, But They’ve Been Wrong Before: Cautious Messaging Is Warranted
As the Delta variant wave of Covid-19 begins to recede in the U.S., experts are proclaiming the worst is behind us. Well, maybe. Let’s hope. But, the experts have been wrong before, many times, as have our political leaders. It’s time we reassess messa…
A Neanderthal Gene That Protects Us From Covid-19 (Part 14)
A new study offers a deep glimpse into a gene, OAS1, that appears to have the power to knock out SARS-CoV-2.
Medicare Reverses Course On Decision To Universally Cover Breakthrough Medical Devices For 4 Years
In January the Centers for Medicare and Medicaid Services (CMS) finalized a rule on coverage of breakthrough medical devices that would allow for coverage for four years. Last month, CMS reversed course, by proposing to rescind the rule due primarily t…
Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly Competitive Market
On September 28th, the FDA approved a once-daily oral medicine, Qulipta (atogepant), for preventive treatment of episodic migraine in adults. It is the second FDA-approved, oral anti-CGRP drug for preventing migraine. The first was Nurtec ODT (rimegepa…
Public Health Is An Afterthought In Biden Administration’s $65 Billion Pandemic Preparedness Initiative
The White House is proposing a $65 billion pandemic preparedness initiative. What’s missing are essential public health components, like plans on how to equitably distribute medical technologies, as well as ways to improve outreach and information camp…
Prospects Diminish For Comprehensive Drug Pricing Reform In The Wake Of Internal Clash Among Democrats
As Democratic leaders try to establish a politically feasible path forward for the budget reconciliation bill, they appear to be caving in to the demands of a small, but influential group of House and Senate centrists who have voiced objections to comp…
